News
Johnson & Johnson Wins First Pinnacle Hip Implant Trial
A Johnson & Johnson (JNJ) unit’s design of a metal-on-metal version of its Pinnacle hip implants isn’t defective, a Dallas jury concluded, ruling against a woman who said the devices poisoned her in the first case of its kind to go to trial.
The ULTAMET artificial hips sold by J&J’s DePuy subsidiary as part of its Pinnacle line of implants had no design defects and the company properly warned patients and doctors about the devices’ risks, jurors in federal court in Dallas concluded. Read more here.
Last modified: Thu, 06 Nov 2014 15:10:30 GMT